Thu. 14 Oct 2021, 4:03pm ETBenzinga
In: Earnings, News
Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(0.65) per share. This is a 10.17 percent decrease over losses of $(0.59) per share from the same period last year. The company reported $10.25 million in sales this quarter. This is a 150.97 percent increase over sales of $4.08 million the same period last year.